S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.14%) $0.928
USD/NOK
(0.23%) $10.87
USD/GBP
(0.02%) $0.792
USD/RUB
(0.02%) $92.60

Realtime updates for Abbott Laboratories [ABL.DE]

Exchange: XETRA Industry: Health Care Equipment & Services
Last Updated28 Mar 2024 @ 12:35

0.34% 104.82

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:35):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices...

Stats
Today's Volume 365.00
Average Volume 555.00
Market Cap 181.88B
EPS €0 ( 2024-01-23 )
Next earnings date ( €0 ) 2024-04-16
Last Dividend €0.510 ( 2023-07-13 )
Next Dividend €0 ( N/A )
P/E 34.82
ATR14 €0 (0.00%)

Abbott Laboratories Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Abbott Laboratories Financials

Annual 2023
Revenue: €40.11B
Gross Profit: €22.13B (55.18 %)
EPS: €3.28
Q4 2023
Revenue: €10.24B
Gross Profit: €5.69B (55.51 %)
EPS: €0.920
Q3 2023
Revenue: €10.14B
Gross Profit: €5.54B (54.60 %)
EPS: €0.830
Q2 2023
Revenue: €9.98B
Gross Profit: €5.50B (55.07 %)
EPS: €0.790

Financial Reports:

No articles found.

Abbott Laboratories Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0.470
(N/A)
€0.470
(N/A)
€0.510
(N/A)
€0.510
(N/A)
€0.510
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Abbott Laboratories Dividend Information - Ex Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.03 - Increase likely (40.59%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.325 2008-01-11
Last Dividend €0.510 2023-07-13
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 64 --
Total Paid Out €22.13 --
Avg. Dividend % Per Year 0.00% --
Score 5.07 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.03
Div. Directional Score 9.76 --
Next Divdend (Est)
(2024-04-01)
€0 Estimate 30.00 %
Dividend Stability
0.80 Very Good
Dividend Score
5.07
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
UDC.DE Ex Dividend Junior 2023-07-10 Annually 0 0.00%
FIE.DE Ex Dividend Junior 2023-07-14 Annually 0 0.00%
NTG.DE Ex Dividend Junior 2023-06-29 Sporadic 0 0.00%
BC8.DE Ex Dividend Knight 2023-05-26 Annually 0 0.00%
XONA.DE Ex Dividend Knight 2023-08-15 Quarterly 0 0.00%
HBC1.DE Ex Dividend Knight 2023-08-10 Semi-Annually 0 0.00%
PSM.DE Ex Dividend Junior 2023-07-03 Annually 0 0.00%
CHV.DE Ex Dividend King 2023-08-17 Quarterly 0 0.00%
ITB.DE Ex Dividend Knight 2023-05-25 Quarterly 0 0.00%
2FE.DE Ex Dividend Knight 2023-04-24 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1431.5007.1510.00[0 - 0.5]
returnOnAssetsTTM0.07821.2007.398.87[0 - 0.3]
returnOnEquityTTM0.1521.5009.4210.00[0.1 - 1]
payoutRatioTTM0.621-1.0003.79-3.79[0 - 1]
currentRatioTTM1.6380.8006.815.45[1 - 3]
quickRatioTTM1.1630.8007.866.29[0.8 - 2.5]
cashRatioTTM0.4981.5008.3410.00[0.2 - 2]
debtRatioTTM0.213-1.5006.44-9.66[0 - 0.6]
interestCoverageTTM19.001.0004.084.08[3 - 30]
operatingCashFlowPerShareTTM4.192.008.6010.00[0 - 30]
freeCashFlowPerShareTTM2.922.008.5410.00[0 - 20]
debtEquityRatioTTM0.405-1.5008.38-10.00[0 - 2.5]
grossProfitMarginTTM0.5521.0004.144.14[0.2 - 0.8]
operatingProfitMarginTTM0.1621.0008.778.77[0.1 - 0.6]
cashFlowToDebtRatioTTM0.4651.0008.538.53[0.2 - 2]
assetTurnoverTTM0.5480.8009.687.74[0.5 - 2]
Total Score12.48

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.261.0006.640[1 - 100]
returnOnEquityTTM0.1522.509.6310.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.922.009.0310.00[0 - 30]
dividendYielPercentageTTM1.8401.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.192.008.6010.00[0 - 30]
payoutRatioTTM0.6211.5003.79-3.79[0 - 1]
pegRatioTTM6.551.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1811.0007.970[0.1 - 0.5]
Total Score7.03

Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators